Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms (Q83190512)
Jump to navigation
Jump to search
scientific article published on 01 April 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms |
scientific article published on 01 April 2006 |
Statements
Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms (English)
Karin Hedenmalm
Cüneyt Güzey
Marja-Liisa Dahl